• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Objectives To test whether a strategy of complete revascularization (CR) as compared with
incomplete myocardial revascularization (IR)—both performed with current “state‐of‐the‐art” …

Objectives: This study sought to assess in patients undergoing transcatheter aortic valve
implantation (TAVI), the prevalence and impact of incomplete coronary revascularization …

OBJECTIVES Ischaemic heart disease is the leading cause of death in the elderly
population. Coronary artery bypass graft (CABG) surgery via sternotomy remains the …

Background To assess clinical outcomes of patients with concomitant severe aortic stenosis
(AS) and coronary artery disease (CAD) who underwent transcatheter aortic valve …

Aortic stenosis (AS) is the most frequent degenerative valvular heart disease in Western
countries and its prevalence increases in parallel with the ageing process of the population …

The aim of personalized medicine is to offer a tailored approach to each patient in order to
provide the most effective therapy, while reducing risks and side effects. The use of …

In patients with multi-vessel coronary artery disease (MVCAD) myocardial revascularization
may be accomplished either on all diseased lesions–complete myocardial revascularization …

Objective Coronary artery bypass grafting (CABG) with incomplete revascularization (ICR) is
thought to decrease survival. We studied the survival of patients with ICR undergoing total …

Introduction Incomplete coronary revascularization is associated with suboptimal outcomes.
We investigated the long‐term effects of Incomplete, Complete, and Supra‐complete …